Profile data is unavailable for this security.
About the company
Notable Labs Ltd, formerly Vascular Biogenics Ltd, is an Israel-based clinical-stage biopharmaceutical company committed to developing next-generation, targeted medicines for difficult-to-treat medical conditions. The Company has created a pipeline of therapeutics that address cancer and immune-inflammatory diseases with the goal of significantly improving patient outcomes and overcoming the limitations of approved treatments. The Company's product candidates are built off of two platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels, and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications.
- Revenue in USD (TTM)311.00k
- Net income in USD-12.39m
- Incorporated2000
- Employees16.00
- LocationNotable Labs Ltd320 Hatch DriveFOSTER CITY 94404United StatesUSA
- Phone+1 (415) 851-2410
- Fax+972 8993-5001
- Websitehttps://notablelabs.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oragenics Inc | 20.63k | -20.26m | 4.62m | 5.00 | -- | 4.47 | -- | 223.71 | -7.98 | -7.98 | 0.0079 | 0.5859 | 0.0026 | -- | -- | 4,126.00 | -258.71 | -97.60 | -312.34 | -106.24 | -- | -- | -98,214.93 | -36,169.75 | -- | -- | 0.0461 | -- | -71.37 | -- | -44.56 | -- | 51.64 | -- |
Emmaus Life Sciences Inc | 28.46m | -4.74m | 4.90m | 55.00 | -- | -- | -- | 0.1722 | -0.0931 | -0.0931 | 0.3905 | -0.6773 | 0.6349 | 0.8184 | 9.36 | 517,454.50 | -10.58 | -- | -- | -- | 93.69 | -- | -16.66 | -- | 0.1249 | 0.1426 | -- | -- | -10.77 | -- | 33.37 | -- | -- | -- |
Biostax Corp | 0.00 | -1.57m | 5.01m | -- | -- | -- | -- | -- | -0.0188 | -0.0188 | 0.00 | -0.058 | 0.00 | -- | -- | -- | -390.77 | -81.51 | -- | -- | -- | -- | -- | -- | -- | -6.05 | -- | -- | -- | -- | 53.32 | -- | -- | -- |
Synaptogenix Inc | 0.00 | -12.23m | 5.01m | 5.00 | -- | 0.1998 | -- | -- | -37.38 | -37.38 | 0.00 | 21.08 | 0.00 | -- | -- | 0.00 | -13.75 | -40.33 | -15.54 | -43.36 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -142.17 | -- | -3.21 | -- |
Clearmind Medicine Inc | 0.00 | -6.92m | 5.03m | -- | -- | 1.08 | -- | -- | -14.57 | -14.57 | 0.00 | 1.40 | 0.00 | -- | -- | -- | -93.26 | -218.20 | -173.29 | -488.96 | -- | -- | -- | -- | -- | -4.68 | 0.00 | -- | -- | -- | -25.03 | -- | -- | -- |
Allarity Therapeutics Inc | 0.00 | -20.94m | 5.07m | 5.00 | -- | -- | -- | -- | -599.34 | -599.34 | 0.00 | -18.88 | 0.00 | -- | -- | 0.00 | -100.46 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.02 | -- | -- | -- |
Notable Labs Ltd | 311.00k | -12.39m | 5.09m | 16.00 | -- | 0.4405 | -- | 16.35 | -2.31 | -2.31 | 0.0622 | 1.28 | 0.0142 | -- | -- | 19,437.50 | -56.70 | -52.02 | -74.10 | -62.09 | 37.30 | 60.19 | -3,984.24 | -3,636.93 | -- | -- | 0.0271 | -- | -52.89 | -11.93 | 65.13 | -- | -50.69 | -- |
Creative Medical Technology Holdings Inc | 9.00k | -5.28m | 5.12m | 4.00 | -- | 0.557 | -- | 568.46 | -3.74 | -3.74 | 0.0064 | 6.81 | 0.0007 | 0.4291 | -- | 2,250.00 | -42.47 | -110.00 | -43.88 | -- | 60.00 | 65.82 | -58,624.33 | -7,961.14 | 23.53 | -- | 0.00 | -- | -89.84 | -40.86 | 47.88 | -- | -- | -- |
Lixte Biotechnology Holdings Inc | 0.00 | -4.69m | 5.22m | 3.00 | -- | -- | -- | -- | -2.38 | -2.38 | 0.00 | 1.39 | 0.00 | -- | -- | 0.00 | -118.45 | -104.18 | -130.17 | -111.05 | -- | -- | -- | -- | -- | -1,253.20 | 0.00 | -- | -- | -- | 19.41 | -- | -- | -- |
Helix BioMedix, Inc. | 2.07m | -2.58m | 5.28m | 8.00 | -- | 3.38 | -- | 2.56 | -15.60 | -15.60 | 12.48 | 6.95 | 0.8047 | 1.87 | 4.55 | 258,238.80 | -100.64 | -146.31 | -120.73 | -173.57 | 68.96 | 30.80 | -125.06 | -527.12 | 1.69 | -14.57 | 0.00 | -- | 122.07 | 92.80 | 67.73 | -- | -29.08 | -- |
Halberd Corp | 281.24k | 25.34k | 5.34m | 3.00 | 3.62 | -- | 210.54 | 18.99 | 0.0023 | 0.0023 | 0.0018 | -0.0002 | 0.1449 | 0.0303 | 2.52 | -- | 1.31 | -- | 4.58 | -- | 50.00 | -- | 9.01 | -- | 0.2661 | 1.35 | 1.02 | -- | 271.52 | -- | -60.11 | -- | -- | -- |
Pasithea Therapeutics Corp | 0.00 | -16.10m | 5.40m | 8.00 | -- | 0.2718 | -- | -- | -14.03 | -14.17 | 0.00 | 19.06 | 0.00 | -- | -- | 0.00 | -49.97 | -- | -53.80 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -32.23 | -- | -- | -- |
BioCardia Inc | 468.00k | -10.34m | 5.44m | 16.00 | -- | -- | -- | 11.63 | -7.04 | -7.04 | 0.3132 | -1.27 | 0.0954 | -- | 4.44 | 29,250.00 | -210.81 | -107.34 | -1,190.90 | -154.17 | -- | -- | -2,208.76 | -1,779.24 | -- | -- | -- | -- | -64.72 | -5.26 | 2.82 | -- | -28.89 | -- |
Tron Pharmaceuticals Inc | 1.01m | -549.47k | 5.50m | 50.00 | -- | -- | -- | 5.45 | -0.0034 | -0.0034 | 0.0062 | -0.0508 | -- | -- | -- | 20,191.00 | -- | -- | -- | -- | 60.28 | -- | -110.51 | -- | 0.0417 | -433.32 | -- | -- | 0.3272 | -- | -39.70 | -- | -- | -- |
Fresh Tracks Therapeutics Inc | 8.01m | -5.69m | 5.55m | 4.00 | -- | 0.5591 | -- | 0.6934 | -1.38 | -1.38 | 1.49 | 1.66 | 0.7326 | -- | -- | 2,001,500.00 | -52.10 | -89.76 | -66.50 | -115.24 | -- | -- | -71.12 | -442.61 | -- | -1,272.00 | 0.00 | -- | 15.31 | 37.62 | 73.02 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Squarepoint OPS LLCas of 31 Mar 2024 | 63.70k | 0.71% |
Mariner LLCas of 31 Mar 2024 | 22.00k | 0.24% |
Morgan Stanley & Co. LLCas of 31 Mar 2024 | 19.30k | 0.21% |
Two Sigma Securities LLCas of 31 Mar 2024 | 14.44k | 0.16% |
XTX Markets LLCas of 31 Mar 2024 | 10.19k | 0.11% |
Wells Fargo Clearing Services LLCas of 31 Mar 2024 | 5.00k | 0.06% |
UBS Securities LLCas of 31 Mar 2024 | 3.93k | 0.04% |
Group One Trading LPas of 31 Mar 2024 | 1.27k | 0.01% |
Securities America Advisors, Inc.as of 31 Mar 2024 | 630.00 | 0.01% |
Harel Mutual Funds Ltd.as of 31 Mar 2024 | 314.00 | 0.00% |